You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 6, 2025

Drug Price Trends for NDC 58657-0528


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 58657-0528

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for the Pharmaceutical Industry: Implications for NDC 58657-0528

Introduction

The pharmaceutical industry is a complex and dynamic sector, influenced by a myriad of factors including regulatory requirements, market demand, and technological advancements. This article will delve into the current market trends, price projections, and the role of the National Drug Code (NDC) system, with a focus on the implications for a specific drug identified by the NDC 58657-0528.

Understanding the National Drug Code (NDC) System

The NDC is a unique, three-segment number that serves as the FDA’s identifier for drugs. It consists of a labeler code, product code, and package code, providing a universal product identifier for human drugs[1][5].

Current Market Trends in the Pharmaceutical Industry

Global Pharmaceutical Market Growth

The global pharmaceutical market is expected to see robust growth, driven by factors such as ageing populations, emerging market demand, and the introduction of new products. In 2024, global pharmaceutical output is forecast to increase by 3%, with regions like the Asia Pacific and the Middle East showing the largest annual growth rates[3].

US Pharmaceutical Market

In the United States, the pharmaceutical market is projected to grow from $846.72 billion in 2022 to $1.28 trillion by 2030, representing a Compound Annual Growth Rate (CAGR) of 5.36%. This growth is driven by increasing pharmaceutical production capacity, greater approvals of generic drugs, and escalating R&D investments[4].

Specialty Pharmaceuticals

Specialty pharmaceuticals, which treat high-cost, complex, or chronic conditions, are a significant driver of market growth. These include drugs for cancer, infectious diseases, autoimmune diseases, and pulmonary conditions. The projected price increase for specialty medications is 4.18%, with weight loss drugs and gene therapies being key contributors[2].

Price Projections and Influencing Factors

Drug Price Inflation

Vizient, Inc. projects a 3.8% drug price inflation in the latest Pharmacy Market Outlook, driven in part by the increasing utilization of specialty pharmaceuticals, including weight loss drugs like GLP-1 agonists. This inflation rate is the highest since July 2019[2].

Impact of Biosimilars

Biosimilars are expected to increase in market share, with a minimal price increase of 0.55%. While biosimilars for drugs like adalimumab (Humira) are gaining traction, they are still not mandated at the payer level, which affects their immediate market impact[2].

Regulatory and Government Influences

Government initiatives to reduce drug prices can significantly impact the industry. For instance, the US government's steps to lower pharmaceutical prices for consumers could affect the margins of branded pharmaceuticals, despite their current robust cash flow and credit profiles[3].

Specific Considerations for NDC 58657-0528

Identification and Listing

To understand the market dynamics and price projections for a drug with the NDC 58657-0528, it is crucial to identify the drug and its category. The NDC Directory contains information on active and certified finished and unfinished drugs, including prescription, over-the-counter, and compounded drug products[1].

Market Category and Demand

If the drug falls under the category of specialty pharmaceuticals or treats chronic conditions, it is likely to be influenced by the trends in these segments. For example, if it is a weight loss drug or a medication for a chronic condition, it would benefit from the growing demand in these areas[2][3].

Pricing Trends

Given the overall trend of a 3.8% drug price inflation, a drug with NDC 58657-0528 would likely see a similar or slightly higher increase, depending on its market category and demand. Specialty drugs, in particular, are expected to see a 4.18% price increase[2].

Regional Market Dynamics

United States

In the US, the pharmaceutical market is characterized by robust sales and low credit risk. The ageing population and increasing demand for weight-loss drugs will drive growth in the coming years. However, drug pricing regulation could impact the industry's profitability[3].

Asia Pacific and China

Regions like the Asia Pacific and China are expected to see significant growth, driven by government support for innovation and a growing middle class that can afford high-value-added drugs. This could influence global pricing dynamics and market competition[3].

Technological Advancements and R&D

Role of AI in Drug Discovery

The increasing adoption of AI-based tools in drug discovery is a key trend in the pharmaceutical industry. This could lead to more efficient and cost-effective drug development, potentially affecting the pricing and availability of drugs in the long term[4].

Key Takeaways

  • Global Growth: The global pharmaceutical market is expected to grow robustly, driven by ageing populations and emerging market demand.
  • US Market: The US pharmaceutical market is projected to reach $1.28 trillion by 2030, with a CAGR of 5.36%.
  • Specialty Pharmaceuticals: These drugs are driving market growth, with a projected price increase of 4.18%.
  • Regulatory Influences: Government initiatives to reduce drug prices can impact industry profitability.
  • Technological Advancements: AI-based tools are emerging as crucial in drug discovery, potentially affecting future drug development and pricing.

FAQs

What is the National Drug Code (NDC) and its significance?

The NDC is a unique, three-segment number that serves as the FDA’s identifier for drugs, providing a universal product identifier for human drugs[1][5].

How is the pharmaceutical market expected to grow in the coming years?

The global pharmaceutical market is forecast to grow by 3% in 2024, driven by ageing populations and emerging market demand. The US market is projected to reach $1.28 trillion by 2030[3][4].

What factors are driving the increase in drug prices?

The increase in drug prices is driven by the growing utilization of specialty pharmaceuticals, including weight loss drugs and gene therapies, as well as regulatory and government influences[2].

How do biosimilars impact the pharmaceutical market?

Biosimilars are expected to increase in market share with minimal price increases, potentially reducing the market share of originator products like Humira[2].

What role does AI play in the pharmaceutical industry?

AI is emerging as a crucial tool in drug discovery, potentially making drug development more efficient and cost-effective[4].

Sources

  1. FDA's National Drug Code Directory - FDA
  2. Vizient Projects 3.8% Drug Price Increase Driven by Specialty Pharmaceuticals - Vizient, Inc.
  3. Industry Trends Pharmaceuticals September 2024 - Atradius
  4. US Pharmaceutical Market Review 2020-2023 and Forecast - GlobeNewswire
  5. National Drug Code Database Background Information - FDA

More… ↓

⤷  Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.